Spire Healthcare Group PLC · LSE:SPI
Spire Healthcare — Investor Presentation (October 2010)
63 slides from Spire Healthcare's investor presentation, Oct 20, 2010
Slide 1: Cardiac Arrhythmias: An Update
Cardiac Arrhythmias: An Update Dr N.M.Gandhi Consultant Cardiologist Spire Gatwick Park Hospital, Horley East Surrey Hospital, Redhill Royal Sussex County Hospital, Brighton
Slide 2: Objectives
Objectives • Identify common arrhythmias encountered by the family physician • Discuss initial Mg options • AF and Ventricular arrhythmias case studies • Which patients needs to be referred? ECG examples
Slide 3: The Conduction System
THE CONDUCTION SYSTEM
Slide 4: Atrial Depolarization
Atrial Depolarization
Slide 5: Ventricular Depolarization
Ventricular Depolarization
Slide 6: Cardiac Arrhythmias
CARDIAC ARRHYTHMIAS Disturbances of either : • Impulse generation • Impulse propagation
Slide 7: Electrophysiologic Principles: Arrhythmias
ELECTROPHYSIOLOGIC A R PRINCIPLES R H Y BRADYARRHYTHMIAS T H M • SINUS NODE DYSFUNCTION I • AV CONDUCTION DISTURBANCES A S TACHYARRHYTMIAS •ATRIAL TACHYCARDIAS •VENTRICULAR TACHYCARDIA
Slide 8: Bradyarrhythmias
Bradyarrhythmias • Impulse formation: – Decreased automaticity: Sinus bradycardia • Impulse conduction: – Conduction blocks: 1º, 2º, 3º AV blocks
Slide 9: Tachyarrythmias
Tachyarrythmias • Impulse formation – Enhanced automaticity: • Sinus node: sinus tachycardia • Ectopic focus: Ectopic atrial tachycardia – Triggered activity • Early afterdepolarization: torsades de pointes • Digitalis-induced SVT • Impulse conduction – Reentry: Paroxysmal SVT, atrial flutter and fi
Slide 10: Normal Sinus Rhythm
Normal Sinus Rhythm www.uptodate.com Implies normal sequence of conduction, originating in the sinus node and proceeding to the ventricles via the AV node and His-Purkinje system. EKG Characteristics: Regular narrow-complex rhythm Rate 60-100 bpm Each QRS complex is proceeded by a P wave P wave is u
Slide 11: PAC
PAC • Benign, common cause of perceived irregular rhythm • Can cause sxs: “skipping” beats, palpitations • No treatment, reassurance • With sxs, may advise to stop smoking, decrease caffeine and ETOH • Can use beta-blockers to reduce frequency
Slide 12: PVC
PVC • Extremely common throughout the population, both with and without heart disease • Usually asymptomatic, except rarely dizziness or fatigue in patients that have frequent PVCs and significant LV dysfunction
Slide 13: PVC
PVC • Reassurance • Optimize cardiac and pulmonary disease management • Beta-blocker • Ablation in a small number of cases
Slide 14: Bradyarrhythmias
Bradyarrhythmias • Impulse formation: – Decreased automaticity: Sinus bradycardia • Impulse conduction: – Conduction blocks: 1º, 2º, 3º AV blocks
Slide 15: Sinus Bradycardia
Sinus Bradycardia • HR< 60 bpm; every QRS narrow, preceded by p wave • Can be normal in well-conditioned athletes • HR can be 30 bpm in adults during sleep, with up to 2 sec pauses
Slide 16: Sinus arrhythmia
Sinus arrhythmia • Usually respiratory--Increase in heart rate during inspiration • Exaggerated in children, young adults and athletes—decreases with age • Usually asymptomatic, no treatment or referral • Can be non-respiratory, often in normal or diseased heart, seen in digitalis toxicity • Referra
Slide 17: Sick Sinus Syndrome
Sick Sinus Syndrome •All result in bradycardia •Sinus bradycardia with a sinus pause •Often result of tachy-brady syndrome: where a burst of atrial tachycardia (such as afib) is then followed by a long, symptomatic sinus pause/arrest, with no breakthrough junctional rhythm.
Slide 18: 1st Degree AV Block
1st Degree AV Block • PR interval >200ms • If accompanied by wide QRS, refer to cardiology, high risk of progression to 2nd and 3rd deg block • Otherwise, benign if asymptomatic
Slide 19: 2nd Degree AV Block Mobitz type I (Wenckebach)
2nd Degree AV Block Mobitz type I (Wenckebach) • Progressive PR longation, with eventual non-conduction of a p wave • May be in 2:1 or 3:1
Slide 20: 2nd degree block Type II (Mobitz 2)
2nd degree block Type II (Mobitz 2) • Normal PR intervals with sudden failure of a p wave to conduct • Usually below AV node and accompanied by BBB or fascicular block • Often causes pre/syncope; exercise worsens sxs • Generally need pacing, possibly urgently if symptomatic
Slide 21: 3rd Degree AV Block
3rd Degree AV Block • Complete AV disassociation, HR is a ventricular rate • Will often cause dizziness, syncope, angina, heart failure • Can degenerate to Vtach and Vfib • Will need pacing, urgent referral
Slide 22: Tachyarrythmias
Tachyarrythmias • Impulse formation – Enhanced automaticity: • Sinus node: sinus tachycardia • Ectopic focus: Ectopic atrial tachycardia – Triggered activity • Early afterdepolarization: torsades de pointes • Digitalis-induced SVT • Impulse conduction – Reentry: Paroxysmal SVT, atrial flutter and fi
Slide 23: Supraventricular Tachycardias
SUPRAVENTRICULAR T. • Sinus Tachycardia • Atrial flutter • Atrial fibrilation • Paroxysmal Supraventricular • Multifocal Atrial T. • Preexcitation Syndrome (Wolff-Parkinson- white Sy.)
Slide 24: Sinus tachycardia
Sinus tachycardia • HR > 100 bpm, regular • Often difficult to distinguish p and t waves
Slide 25: Paroxysmal Supraventricular T.
Paroxysmal Supraventricular T. • Sudden onset and termination • Atrial rates of 140 to 250 /min • Normal QRS complexes • The mechanism is most often reentry.
Slide 26: Paroxysmal Supraventricular Tachycardia
Paroxysmal Supraventricular Tachycardia • Refers to supraventricular tachycardia other than afib, aflutter and MAT • Usually due to reentry—AVNRT or AVRT
Slide 27: PSVT
PSVT • CSM or adenosine commonly terminate the arrhythmia, esp, AVRT or AVNRT • Can also use CCB or beta blockers to terminate, if available • Counsel to avoid triggers, caffeine, Etoh, pseudoephedrine, stress
Slide 28: Multifocal Atrial T.
Multifocal Atrial T. • Is due to enchanced automaticity within the atria, resulting in abnormal discharges from several ectopic foci • Most often occurs in the setting of severe pulmonary disease and hypoxemia. • EKG: irregular rhythm with multiple (at leats 3) P waves morphologies
Slide 29: Atrial flutter
Atrial flutter • Is caracterized by rapid coarse “sawtooth” appearing atrial activity, at rate of 250 to 350 x min. – Many of these fast impulses reach the AV node during its refractory period, so that the ventricular rate is generally lower. • Frequently it degenerates into atrial fibrilation – The
Slide 30: Preexcitation Syndrome
Preexcitation Syndrome • Wolff-Parkinson-White Syndrome • EKG: Although different types of bypass tracts have been identified, the bundle of Kent, is the most common and can usually conduct in both the anterograde and retrograde directions.
Slide 31: Atrial Fibrillation
Atrial Fibrillation • Irregular rhythm • Absence of definite p waves • Narrow QRS • Can be accompanied by rapid ventricular response
Slide 32: Atrial fibrillation management
Atrial fibrillation-- management • Rhythm vs Rate control—if onset is within last 24-48 hours, may be able to arrange cardioversion—use heparin around procedure • Need TEE if valvular disease (high risk of thrombus) • If unable to definitely conclude onset in last 24-48 hours: need 4-6 weeks of anti
Slide 33: Atrial Fibrillation: Clinical Problems
Atrial Fibrillation: Clinical Problems • Embolism and stroke (presumably due to LA clot) • Acute hospitalization with onset of symptoms • Anticoagulation, especially in older patients (> 75 yr.) • Congestive heart failure – Loss of AV synchrony – Loss of atrial “kick” – Rate-related cardiomyopathy d
Slide 34: AF: Medical Management
AF: Medical Management • Treatment of underlying cause • Ventricular rate control • Anticoagulation • Antiarrhythmics with a view to restore sinus rhythm
Slide 35: Control of Ventricular Rate in Atrial Fibrillation
Control of Ventricular Rate in Atrial Fibrillation • Betablockers • Calcium channel blockers Verapamil, diltiazem • Digoxin • Amiodarone
Slide 36: Anticoagulation
Anticoagulation
Slide 37: Anticoagulation
Anticoagulation • Assessment of bleeding risk should be part of the clinical assessment of AF patients prior to starting anticoagulation • Antithrombotic benefits and potential bleeding risks of long-term coagulation should be explained and discussed with the patient • Aim for a target INR of betwee
Slide 38: CHADS2 scoring
CHADS 2 scoring CCF 1 point Hypertension 1 point Age > 75 1point Diabetes 1 point Stroke/TIA 2 points • Any patients with AF with a score of =/>2 would benefit from being on Warfarin
Slide 39: Cardioversion
Cardioversion
Slide 40: Cardioversion
Cardioversion • Cardioversion results in SR in at least 90% of cases • SR is only maintained in 30-50% at one year • Class 1a, 1c and III agents increase likelihood of maintained SR from 30-50% to 50-70% at one year
Slide 41: Follow-up
Follow-up • Follow-up after cardioversion should take place at 1 month, and the frequency of subsequent reviews should be tailored to the patient • Reassess the need for anticoagulation at each review
Slide 42: Catheter Ablation for AF
Catheter Ablation for AF
Slide 43: AF termination during PV isolation
AF termination during PV isolation (a) Baseline (CL 171 ms)
Slide 44: AF Ablation
AF Ablation • Success rates – approx 70% but may require repeat procedure – Often increase in symptoms for first 3-6 months after procedure does not indicate failure • Risks – damage to existing conduction mandating pacing – Cardiac perforation/tamponade – Bleeding – Stroke/thromboembolism – Death
Slide 45: Catheter Ablation: Indications
Catheter Ablation: Indications • Symptomatic patients • Refractory to Antiarrhythmics • Medical therapy contraindicated due to co- morbidities or intolerance NICE 2006
Slide 46: Which AF patients need Specialist Referral?
Which AF patients need Specialist Referral? • Patients with: - WPW syndrome - Uncontrolled ventricular rate (> 200/min) - Tachy-brady syndrome - For rhythm control strategy - CCF - Intolerant to Drugs - Invasive options
Slide 47: Ventricular Arrhythmias
VENTRICULAR ARRHYTHMIAS • Ventricular tachycardia • Torsades De Pointes • Ventricular fibrillation
Slide 48: Ventricular tachycardia
Ventricular tachycardia • Is divided in 2 categories: – If it persist for more than 30 seconds “sustained VT” – Less than 30 seconds: “nonsustained VT” • Symptoms vary depending on the duration. – Major manifestations are hypotension and loss of consciousness.
Slide 49: Non-sustained ventricular tachycardia
Non-sustained ventricular tachycardia • Need to exclude heart disease with Echo and stress testing • May need anti-arrhythmia treatment if sxs • In presence of heart disease, increased risk of sudden death • Need referral for EPS and/or prolonged Holter monitoring • ICD may be life saving
Slide 50: Torsades De Pointes
Torsades De Pointes • Varying amplitudes of the QRS. • It can be produced by afterdepolarizations (triggered activity). • Particularly in prolonged QT interval. • Occur with some drugs (quinidine), electrolite disturbances, and congenital prolongation of the QT interval.
Slide 51: Specialist Referral: ECG Examples
Specialist Referral ECG Examples
Slide 52: Supraventricular Tachycardia (SVT)
Slide 53: satibaibsypeneseeatagead i
satibaibsypeneseeatagead i ia rg eet eat aue f HATH teeth lle ad pigar eens te pips} caane os Tet TR be eee b186) 8 soe tt 3 ae oe ee ee
Slide 54: tt
tt
Slide 55: Slide 55
Slide 56: Slide 56
Slide 57: Slide 57
Slide 58: con
con C4 Savi diemali VR Gee eee | aVF : A 1 | r] ae | | of | | |
Slide 59: Lemme WKAal : | d A,
Lemme WKAal : | d A, yy Lanapaiannrssa h H WU. ii ii WWW
Slide 60: Slide 60
Slide 61: OKT. 13:
49:1 OKT. 27 13: 23 38
Slide 62: Slide 62
Slide 63: Contact
Contact... * E-mail: [email protected] [email protected] * Fax: 01737 231938 * Phone: Spire - 01293 785511 ESH - 01737 768511, ext.6333
Spire Healthcare Group — Investor Presentation (October 2010) on 6ix